Katende, David
Nalweyiso, Norah
Nabulime, Gertrude
Nakuya, Kevin
Mubiru, Michael Charles
Sekitoleko, Isaac
Baisley, Kathy
Nyirenda, Moffat
Grosskurth, Heiner
Funding for this research was provided by:
MRC UVRI and LSHTM Uganda Research Unit (NCD capacity building grant - PhD studentship)
Article History
Received: 5 February 2023
Accepted: 22 August 2023
First Online: 7 September 2023
Declarations
:
: The authors declare no competing interests.
: The study was approved by the Research and Ethics Committee of the Uganda Virus Research Institute (GC/127/19/09/743), the Uganda National Council for Science and Technology (HS 2714) and the Ethics Committee of the London School of Hygiene and Tropical Medicine (17914).
: Participants read or were read to the appropriate participant information and consent form (ICF) to acquaint themselves with what the current study entailed and what was required of them to participate. Both verbal and written informed consent was obtained from all participants in this study. This was documented on the ICF by the participant’s own signature, or thumbprint obtained from those not able to read or write in the presence of a competent independent witness. The witness also underwrote and signed on that participant’s behalf.
: Research on human subjects or material or data in this study was conducted in compliance the Declaration of Helsinki and followed Good Clinical Practice (GCP) guidelines. All study staff were also GCP trained. Patients with uncontrolled NCDs detected during the outcome assessment at health facilities were jointly discussed with the healthcare provider at their respective facility to ensure that they receive adequate care.
: Not applicable as no identifiable data is presented in the current study.